Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2018 (2018), Article ID 9010353, 6 pages
https://doi.org/10.1155/2018/9010353
Research Article

Mutational Profiling of Non-Small-Cell Lung Cancer Resistant to Osimertinib Using Next-Generation Sequencing in Chinese Patients

1Department of Radiotherapy, Qingdao Cancer Hospital, Qingdao 266042, China
2Department of Oncology, The Affiliated Hospital of Qingdao University, Qingdao 266002, China
3Department of Oncology, The Affiliated Qingdao Central Hospital of Qingdao University, Qingdao 266042, China
4Oncology Genemic, Geneplus Beijing, Beijing 100010, China

Correspondence should be addressed to Youxin Ji; moc.liamg@ij987654321

Received 19 December 2017; Revised 23 January 2018; Accepted 6 February 2018; Published 11 March 2018

Academic Editor: Valli De Re

Copyright © 2018 Keke Nie et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Keke Nie, Haiping Jiang, Chunling Zhang, et al., “Mutational Profiling of Non-Small-Cell Lung Cancer Resistant to Osimertinib Using Next-Generation Sequencing in Chinese Patients,” BioMed Research International, vol. 2018, Article ID 9010353, 6 pages, 2018. doi:10.1155/2018/9010353